Roche received expanded approval from the Food and Drug Administration for a test to diagnose breast cancer. The pharmaceutical company said Monday that the FDA approved the PATHWAY HER2 (4B5) test ...

U.S. stocks trimmed some losses in the final hour of trading but remained lower, with tech stocks leading the decline. The ...

Investors looking for a Supreme Court decision on President Donald Trump’s tariffs may now need to look at next year — but ...

On Monday, the Vanguard Value ETF, an exchange-traded fund tracking large-cap value stocks, traded at its best level relative ...

As of Monday, the dollar value of new stock buybacks announced in 2025 has surpassed the previous calendar-year record, ...

Weak retail sales and spending-averse households are pushing China toward targeted stimulus — including offering digital-yuan ...

Investors should watch shares of Exxon Mobil and Bank of America to gauge whether the value-versus-growth rally could persist ...

For the stock market to push higher, the next phase of the bull market will need to see increased corporate margins that ...

ServiceNow’s stock is seeing a rare double-digit drop on Monday, and two factors seem to be driving the pressure.

Worries about an artificial intelligence bubble are likely overstated, as such concerns are mostly concentrated on a few ...

While it’s healthy to see market breadth improving as investors rotate their money out of tech names, it’s important to watch ...

On Oct. 20, front-month WTI traded as low as $56.35, and the January contract lows at around noon ET are just about there with the last trade at $56.41/bbl, down just over $1 on the day. Brent is in a ...